Theme: Autoimmunity: An approach to defeat COVID-19

Autoimmunity 2020

Autoimmunity 2020

 “Autoimmunity 2020” Conference is a global platform to discuss and learn about Immunology, Autoimmune Disease, Infection and Autoimmunity, Autoimmunity in Women, Autoimmune & Inflammatory Diseases, Thyroid Autoimmunity, Therapy of Autoimmune Liver Disease, Immunotherapy, Molecular Immunology, Cancer Immunology, Clinical Immunology, Translational Immunology, Types of Immunology, Immune Diseases, Peptides and Autoimmune Diseases, Prediction, Monitoring and Prevention.

14th International Congress on Autoimmunity” mainly focuses on the gathering and concentrates on the trending advances and development in every aspect of Autoimmunity research which takes an opportunity in meeting, organizing and see the new logical advancements of the specialists and researchers. We foresee a great scientific faculty from Thailand and in addition from different nations with some highly interesting scientific researchers to delegate the occasion. We unconditionally invite all the prominent, Professors, Students and delegates to participate in this upcoming Autoimmunity event to witness a valuable scientific occasion and to participate in Autoimmunity Workshop, Autoimmunity Symposium & contribute to the future innovations in the field of Immunology.

Autoimmunity 2020 is the main gathering where you can find out about immune system illnesses from an assortment of points of view, both research-based and clinical. We will examine the freshest remedial systems and demonstrative instruments just as the most modern research on hereditary, etiology, symptomatic, clinical angles and novel treatments of immune system illnesses. Autoimmunity Conferences furnishes an opportunity to team up with industry peers and find information and assets that can be utilized to accomplish your own and hierarchical objectives

Why to attend?

Autoimmunity is a stage for, (Doctors, investigate researchers, understudies, mechanical and pharma experts) to uncover their exploration work, to Share their insight in resistance maladies. It is a chance to associate with individuals over the globe concentrated on finding out about Immunology. Incredibly famous speakers, the latest treatments and the most recent updates in Autoimmunity for Immunology are signs of this gathering.

Target Audience:

· Allergists

· Immunologists

· Microbiologists

· Pediatricians

· Physicians

· Academicians

· Health Care experts

· Young Research Scholars

· Students

· Society and Organizational Members


Conference Series take the pleasure to proudly present “International Conference on Autoimmunity” during June 22-23, 2020 in Australia with the theme “Modern approaches in autoimmunity”.

Autoimmunity disease is a condition arising from an abnormal immune response to a normal body part. There are at least 80 types of autoimmune diseases. Nearly any body part can be involved. Common symptoms include low grade fever and feeling tired. Often symptoms return and go. it's been calculable that reaction diseases area unit among the leading causes of death among ladies within the u. s. altogether age teams up to 65 years. As a result, health care agencies and market players, through various awareness programs, encourage routine reviews.

The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025. An autoimmune diseaser causes the immune system to destroy its own body tissue. There are more than 80 different types of autoimmune disorders; however, lupus, multiple sclerosis, IBS, type 1 diabetes, rheumatoid arthritis, psoriasis, and others are the most common form of autoimmune disease. Different types of drugs such as anti-inflammatory, NSAIDs, interferons, immune suppressants, corticosteroids, and others, are approved for the treatment of autoimmune disease. It has been estimated that autoimmune diseases are among the leading causes of death among women in the United States in all age groups up to 65 years.

Autoimmune Disease Diagnosis market worldwide is projected to grow by US$2.4 Billion, guided by a compounded growth of 8.1%. While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 6.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$92.5 Million to the region's size and clout in the next 5 to 6 years. Over US$191.5 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Consumables & Assay Kits can reach a market size of US$174.7 Million by the shut of the analysis amount. because the world's second largest economy and therefore the new game changer in international markets, China exhibits the potential to grow at eleven.7% over consequent number of years and add close to US$639.3 Million in terms of available chance for the choosing by aspiring businesses and their sharp leaders.

Asia-Pacific presents lucrative growth opportunities for the key players operating in the autoimmune disease therapeutics market owing to large population base, rise in purchasing power, surge in prevalence of autoimmune disease, and increase in demand for advanced autoimmune disease therapeutics. Growth in number of aging population, and increase in early detection of the disease with rise in healthcare expenditure fuel the growth of the autoimmune disease therapeutics market in this region.

Systemic lupus (SLE) may be a chronic autoimmune disorder with associate degree exaggerated risk of death compared to general population. Though previous studies showed improvement in survival of lupus, the long-run prognosis has not been elaborate in China. All pooled analyses were conducted each for random-effects model and fixed-effects model. Funnel plots and lasiocampid regression tests were applied to envision potential publication bias. No uniformity was tested by sensitivity analysis. We tend to known five studies for survival analysis comprising 4469 Chinese patients with lupus (380 discovered deaths). Thirty-six studies were appropriate for death-cause analysis with 2179 discovered deaths (derived from over twenty, Chinese patients with SLE). The overall pooled survival rates for SLE in China were 94% for 5-year survival rate and 89% for 10-year survival rate after disease onset from the year 1995 to 2013, which were similar with previous publications in Asia-Pacific area. The proportions of various causes of death showed infection (33.2%), urinary organ involvement (18.7%), lupus neurological disorder (13.8%), and upset (11.5%) because the high four causes.

Autoimmune diseases are a broad range of more than 80 related disorders that range from common to rare. They affect around 5% of people and are one of the most important chronic health problems in Australia and New Zealand. Common reaction diseases like rubor, arthritis and polygenic disease have an effect on quite 1 Chronicles of individuals. Lupus (SLE) affects but zero.1% of individuals and is a lot of common and severe in autochthonal Australians, Polynesians and folks descended from South East Asia.





The 35th International Conference on Vaccines and Immunization (Vaccines & Immunization 2019) hosted by Conference Series LLC Ltd took place at Brisbane, Australia during November 12-13, 2019. It was organized by Conference Series LLC Ltd and generous response was received from the Editorial Board Members of Conference Series LLC Ltd Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2019 from Conference Series LLC Ltd. The two day program witnessed thought provoking Keynote and Plenary presentations from experts in the field of Vaccines and Immunization, highlighting the theme, “Scrutinizing Recent Advancements in Vaccines & Immunization".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Vaccines         
  • Vaccine Preventable Diseases 
  • Immunization 
  • Veterinary Vaccines   
  • Vaccines against Infectious Diseases  
  • Plant-Based Vaccines 
  • Types of Immunology
  • Immunoresearch & Immunotechnology         
  • Autoimmune & Inflammatory Diseases          
  • Immune Diseases        
  • Making a Session Plan
  • Giving Vaccinations    ‎
  • HIV Vaccines 
  • Vaccines Production and Development          
  • Onco Immunology      
  • Zika Virus Vaccines   
  • Protein Based Vaccines          
  • Tuberculosis Vaccines
  • Toxoid Vaccines

The highlights of the meeting were the keynote lectures from

  • Ivana Haluskova Balt, French Society of Immunology, France
  • Rod Cook, James Cook University, Australia
  • Igor Klepikov, Tel-Aviv Medical Center, Russia
  • Dina Arisonaningtyas, Public Health and Nursing Universitas Gadjah Mada, Indonesia

Vaccines & Immunization 2019 played an important role in promoting multidisciplinary interactions between Science and Medicine to enhance research in Vaccines and Immunization. The program covered current and emerging research innovations in the field of Vaccines and Immunology.

We would specially thank the Moderators Rod Cook, James Cook University, Australia for him contribution for the conference. We would also like to thank Igor Klepikov, Tel-Aviv Medical Center, Russia and Dina Arisonaningtyas, Public Health and Nursing Universitas Gadjah Mada, Indonesia for Speakers at our conference sessions.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Vaccines & Immunization 2019 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series LLC would like to announce the commencement of “14th International Congress on Autoimmunity during June 22-23, 2020 at Brisbane, Australia".

For more Details about the Conference please visit:

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 22-23, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View